Press releases
- Tandem Diabetes Care Prices Upsized Private Placement of $275.0 Million of Convertible Senior Notes Due 2029
- Tandem Diabetes Care Announces Fourth Quarter and Full Year 2023 Financial Results and 2024 Financial Guidance
- Tandem Diabetes Care Launches Tandem Mobi, the World’s Smallest, Durable Automated Insulin Delivery System
- Tandem Diabetes Care Announces Upcoming Conference Presentations
- Tandem Diabetes Care to Announce Fourth Quarter and Full Year 2023 Financial Results on February 21, 2024
- Tandem Diabetes Care’s t:slim X2™ Insulin Pump is the First Automated Insulin Delivery System to Integrate with Abbott’s New FreeStyle Libre® 2 Plus Sensor
More ▼
Key statistics
As of last trade Tandem Diabetes Care Inc (TD5A:DUS) traded at 31.84, -19.06% below its 52-week high of 39.34, set on Apr 11, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 31.84 |
---|---|
High | 31.84 |
Low | 31.84 |
Bid | 32.54 |
Offer | 32.72 |
Previous close | 30.78 |
Average volume | 112.00 |
---|---|
Shares outstanding | 65.63m |
Free float | 65.21m |
P/E (TTM) | -- |
Market cap | 2.32bn USD |
EPS (TTM) | -3.44 USD |
Data delayed at least 15 minutes, as of Mar 28 2024 07:10 BST.
More ▼